Luis Iglesias will become Head of Santen EMEA (Geneva) from 1 April 2018, as a successor to Shigeo Taniuchi who will return to Japan to become President and Chief Operating Officer of the parent company, Santen Pharmaceutical Co. When Luis joined Santen in September 2017 as Senior Vice President, Commercial – EMEA, he brought with him more than twenty five years’ experience in pharmaceuticals in Europe and the US, with a particular specialism in ophthalmology and medical devices.